How SHANK3 Got to Clinical Trials So Fast | Guoping Feng
Dr. Feng explains why SHANK3 moved into clinical trials quickly — and what it takes (money, people, focus) to translate science to patients. Full interview on GENEration Hope.
Back to ClipsMore clips
Gene Therapy Weekly: CRISPR's Biggest Trial Result Yet | GENEration Hope
Update for the week of April 27, 2026 A CRISPR-based treatment just delivered pivotal Phase 3 results for a rare and debilitating disease — and for rare disease families, this is a milestone worth understanding. This week, Ron breaks dow...
“If We Solve This… I’ll Be the Happiest Person” | Guoping Feng
Dr. Feng talks about the reality families live with — and what it would mean if we could truly treat severe neurodevelopmental disorders. Full interview on GENEration Hope.
“It’s Technical — We Can Solve It” | Why He’s Optimistic
Dr. Feng explains why many monogenic neurodevelopmental disorders feel solvable now — if we put enough people and resources behind them. Full interview on GENEration Hope.